{"id":"W2589192293","doi":"10.1200/jco.2015.33.7_suppl.196","title":"Association of changes in biomarkers with treatment with cabozantinib (Cabo) in metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the 100mg nonrandomized expansion cohort of a randomized discontinuation trial.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Cabozantinib; Prostate cancer; Oncology; Cohort; Discontinuation; Biomarker; Response Evaluation Criteria in Solid Tumors; Cancer; Randomized controlled trial; Clinical trial; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00291385,0.0004522865,0.001046591,0.0003093607,0.0001972281,0.0004887443,0.0003542384,0.0005065268,0.001755471],"category_scores_gemma":[0.002488188,0.0002419259,0.001093367,0.0003667647,0.0003315086,0.000383723,0.0002980531,0.0007982704,0.0001875133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004379099,"about_ca_system_score_gemma":0.0005174376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004586669,"about_ca_topic_score_gemma":0.0009494803,"domain_scores_codex":[0.9988068,0.0006926371,0.00006530617,0.0001691606,0.0001401327,0.0001259669],"domain_scores_gemma":[0.9971284,0.001205989,0.0008802153,0.0002514173,0.0001464552,0.0003874698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.76468,0.002578889,0.2021639,0.0002310422,0.002697723,0.0001549982,0.00009450392,0.0006888108,0.009874487,0.00003992136,0.0005063629,0.01628941],"study_design_scores_gemma":[0.03840696,0.1407711,0.8107101,0.00002226302,0.002367096,0.0003335434,0.00008551884,0.002631044,0.003345622,0.0001139294,0.00117623,0.00003653037],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989426,0.0004225333,0.00009749395,0.00002127471,0.000008688348,0.0001095286,0.0002541433,0.000006816747,0.0001369069],"genre_scores_gemma":[0.9988683,0.0000755349,0.0001517969,0.00003122291,0.00002143984,0.0001113867,0.0005186747,0.000003707732,0.0002179462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00291385,"threshold_uncertainty_score":0.01541007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03943750518335649,"score_gpt":0.3809152647121456,"score_spread":0.3414777595287891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}